Why Farbe Firma is the Leading Injectable Manufacturer in Samoa
Why Farbe Firma is the Leading Injectable Manufacturer in Samoa
Last Updated: 18 September 2026
TL;DR: Samoa - the independent state, not American Samoa - has no operating medicines registration system, and the Ministry of Health says so in its own current policy: "No product evaluation, registration or listing system exists at the moment." What exists on the statute book is a narrow new-drug gate in the Drugs Act 1967. The real gates are the Essential Medicines List, a Central Warehouse contract, a Samoan importer, and Customs.
Key Takeaways
The Government of Samoa states in its National Medicines Policy and Plan of Action FY2023/24 - FY2027/28 that no product evaluation, registration or listing system exists. That is an absence quoted from the Ministry itself, not a "not found" on our side.
Section 14 of the Drugs Act 1967 is unrepealed and does require approval before a "new drug" is imported. But "new drug" means a substance not previously used in Samoa, so an established generic injectable appears to sit outside it. The 90 days in section 14(3) is a standstill on sale, not an approval timeline.
We found no Samoan list of recognised or stringent regulatory authorities. The closest text is a 2008 policy sentence naming authorities "such as TGA and FDA" - illustrative, not closed. India is unnamed, and nothing says Indian approval is refused.
India's CDSCO appears on WHO's List of transitional WLAs, but the scope column designates it for vaccines only. A tender clause asking for a stringent authority for a medicine is not satisfied by CDSCO, and the Global Fund's definition excludes it too.
Introduction: What an Injectable Manufacturer in Samoa Actually Has to Clear
One clarification belongs at the top. Samoa here means the Independent State of Samoa, capital Apia, currency the Samoan tala. It is not American Samoa, a United States territory whose medicines are governed by the US FDA. Search results and health-statistics tables conflate the two constantly. A supplier who plans around American Samoan law plans around the wrong country's law.
The second point is stranger. Most exporter guides explain how to register a product. For Samoa that framing has no object: the Ministry of Health's current National Medicines Policy and Plan of Action FY2023/24 - FY2027/28 states plainly that no product evaluation, registration or listing system exists at the moment, adding that Samoa applies reliance in the selection of medicines during procurement. Be precise about the evidential weight of that: it is not that we searched and found no register; the Ministry which would run one says there is none.
What Sets a World-Class Injectable Manufacturer in Samoa Apart
What separates a serious supplier here is refusing to over-read that vacuum, because there is law on the books. The governing instrument is the Drugs Act 1967, commenced 24 July 1967, revised as at 31 December 2023. It was the Food and Drugs Act 1967 until the Food Act 2015 removed the food references; older indexes carry the outdated title. Section 14 provides that no person may import or manufacture a new drug unless approved by the Chief Executive Officer of the Ministry of Health - not a chief pharmacist, not a medicines board.
The definitional limit is the whole commercial point. A "new drug" is a substance which has not previously been used in Samoa. The trigger is novelty to the country, not to the supplier or the world, so a molecule already in Samoan use appears to fall outside section 14 altogether - a reading worth confirming with the Ministry rather than assuming. Note also what the section 14 dossier list does not ask for: no GMP certificate, no Certificate of Pharmaceutical Product, no bioequivalence, no site master file. Whether regulations under section 40 add any we could not establish either way.
Quality Systems Behind Every Batch Shipped to Samoa
Farbe Firma manufactures sterile injectables under WHO-GMP certification at ISO Class 5 aseptic filling in Gujarat, India, with in-house HPLC, GC, LAL endotoxin and Karl Fischer testing and ICH Q1A/Q1B stability work. Every batch ships with a certificate of analysis traceable to retained samples, and we prepare CTD and ACTD dossiers as standard for the 30+ countries we export to. The honest word in a Samoan context: nothing in Samoan law we could find requires a WHO-GMP certificate. It is a buyer-facing and donor-facing credential here, not a legal precondition.
Documentation still matters. Samoa participates in the Pacific Medicine Testing Programme, under which Australia's Therapeutic Goods Administration laboratories test five products per country per year free of charge - post-market surveillance, not pre-market assessment. Meanwhile section 12 of the Drugs Act deems the person the label identifies as manufacturer or importer liable for a breach unless they prove otherwise. A supplier enters with no registration to shelter behind, judged by an Australian laboratory, carrying reverse-onus label liability.
Why Farbe Firma is the Trusted Injectable Manufacturer in Samoa for Global Buyers
If entry is not rationed by dossier review, it is rationed by four other things, and those are where we put the effort. First, the Samoa Essential Medicines List, 4th Edition, July 2022, of about 170 medicines - a selection list, not a market authorisation. Second, the Ministry's Pharmaceutical Warehouse, opened in 2016 and also called the Central Warehouse, running on mSupply and procuring through framework contracts. Third, a Samoan importer or pharmacy supervised by a registered pharmacist. Fourth, Customs.
The counterparty question is unusual and favourable. The Government states that it currently finances 100 per cent of the medicine needs of the public sector, so a supplier deals with a paying sovereign customer rather than a donor - though the same policy concedes it cannot pay suppliers on time, and states an intention to blacklist suppliers for untimely delivery. Donations from WHO, UNICEF, UNFPA and bilateral donors including China, India and Australia sit alongside that. We will publish no donor-versus-commercial split and no market size: the Government has not assessed its own market.
Two structural facts read together. Samoa's policy quotes a World Bank assessment that Samoa, like all Pacific island countries, has little alternative other than to pay prices significantly above WHO median prices, and spends less on pharmaceuticals than its disease burden warrants. And the Government commits to using procurement to grow the Samoan private pharmaceutical sector. Both point the same way: partner with a local importer rather than sell around one. Local manufacture is no competing threat - local production is not on the agenda.
Explore Farbe Firma: Products / Global Reach / About Us
Frequently Asked Questions (FAQ)
Do I need to register my injectable product with a Samoan medicines authority?
On the Government's own account there is no registration system to register with. The qualification is section 14 of the Drugs Act 1967, which still requires approval by the Chief Executive Officer before a new drug is imported - "new drug" meaning one not previously used in Samoa. For an established generic molecule that gate appears not to apply, but confirm it with the Ministry.
Is India on a Samoan list of approved countries or recognised regulators?
No such list was found in any Samoan instrument; we looked in the Drugs Act 1967, the Pharmacy Act 2007 and the Ministry's legislation index. The nearest text is a 2008 policy sentence about medicines "internationally recognized by authorities such as TGA and FDA" - note it names the US FDA, not New Zealand's Medsafe, and that "such as" makes it illustrative. India is unnamed, but absence from a non-exhaustive example is not exclusion.
Does CDSCO approval count as a stringent or WHO-Listed authority for Samoa?
Not for a medicine, and this is a trap we would rather you heard from us. CDSCO appears on WHO's List of transitional WLAs, but the scope column designates it for vaccines only; other authorities in the same table carry "Medicines" and India does not. Separately, the Global Fund's stringent-authority definition is limited to ICH members and observers before 23 October 2015, excluding CDSCO and leaving WHO prequalification or the Expert Review Panel. Neither Samoa nor India is a PIC/S member.
What dossier format, fees and timelines should I budget for in Samoa?
We can give no fee schedule, no review timeline and no prescribed dossier format, because none was found - a "not found" rather than a proven absence, partly explained by there being no registration procedure for a format to attach to. Never treat the 90 days in section 14(3) as an approval timeline: it is a standstill on sale, with no decision deadline and no deemed approval. We supply CTD and ACTD regardless.
What should a sterile injectable supplier be most careful about in Samoa?
Presentation design, and we say that with care rather than as a sales angle. Samoa's 2019 measles epidemic killed more than eighty people, most of them children under four; reported tolls differ by cut-off date, 81 as at 28 December 2019 against 83 in total, and we are not choosing between them. It followed a 2018 incident in which two children died after MMR was reconstituted with an expired anaesthetic instead of sterile water. The vaccine was cleared: the failure was handling at the point of care, not manufacture. Diluent pairing, labelling, look-alike vial risk and lot traceability are therefore matters on which a Samoan buyer may reasonably be exacting.
Technically Reviewed By: Maulik Sudani (Technical Expert) | Jignasu Sudani (Technical Expert), Farbe Firma Pvt Ltd, Gujarat, India.
Farbe Firma Pvt Ltd - WHO-GMP certified sterile injectable manufacturer and CDMO, Gujarat, India. ISO Class 5 aseptic filling, CTD/ACTD dossiers, exporting to 30+ countries. director@farbefirma.orgRequest a Quote / View Products / Blog
Comments